SELINEXOR
selinexor 20 mg tablet, 32
SELINEXOR (13104Q)
13104Q
Manner of administration:Oral
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment - Dose requirement of 160 mg per week
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Continuing treatment - Dose requirement of 160 mg per week
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 32 | # of repeats: 2 | DPMQ: $18,720.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Xpovio | |||||